ConductScience.org, home

Gene · 411

ARSB: arylsulfatase B

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. ARSB: arylsulfatase B. Genes, record 411. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/411

On this page

Gene

Symbol
ARSB
HGNC
Name
arylsulfatase B
HGNC
NCBI Gene ID
411
NCBI Gene
HGNC ID
HGNC:714
HGNC
Ensembl
ENSG00000113273
NCBI Gene
Aliases
ASB, G4S, MPS6
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P15848Arylsulfatase B5331Ensembl, GeneID, HGNC

Source UniProt

Patents87

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026067851 A2026-04-21254P15848Espacenet
EP 4650780 A22025-11-192413P15848Espacenet
JP 2025169942 A2025-11-14845P15848Espacenet
JP 2025169942 A2025-11-14846P15848Espacenet
EP 4641201 A22025-10-291991P15848Espacenet
JP 2025147176 A2025-10-061098P15848Espacenet
JP 2025529142 A2025-09-045525P15848Espacenet
WO 2025181336 A12025-09-0469P15848Espacenet
US 12371689 B22025-07-295525P15848Espacenet
JP 2025517969 A2025-06-121991P15848Espacenet

1 to 10 of 87

See all 87 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants734

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleARSB papersNewest fiscal year
R01DK067859Development of Assays for Newborn Screening and for Post-Screening Evaluation of Disease Severity202025
U24AG021886National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)52025
I01BX001819Glia-neuron Interaction in Fetal Alcohol Spectrum Disorders32025
P30ES010126UNC Center for Environmental Health and Susceptibility22025
P30EY010572Ophthalmology Core Facility22025
R01CA215784Mechanisms of arsenic detoxification by the human microbiome22025
R01CA265726Selective pressures from inherited variation impacting myeloproliferative neoplasm initiation22025
R01DK103794Systematic Genetic Dissection of Human Erythropoiesis22025
R01EY019643Extracellular Matrix and Outflow Resistance22025
R01HL146500Next generation functional genomics of hematology traits22025

1 to 10 of 734Source NIH's project files

See all 734 nih grants

Papers1,563

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Molecular characterization of mupirocin-resistant MRSA from Germany and South Africa.Front Cell Infect Microbiol202642643317PubTator, text miningPubMed
Report of Mucopolysaccharidosis Type VI Disorder in Pakistani Patients Presenting Two Novel ARSB Variants.Biochem Genet202642616231PubTator, text miningPubMed
Co-contamination of antimony and arsenic reshapes resistome, virulome, and virome in poultry feces near the world's largest antimony mine.Environ Pollut202642385828PubTator, text miningPubMed
Environmental ubiquity but limited host taxonomic distribution of co-occurring metal(loid)-resistance genes and persistent organic pollutant-transformation genes in global inland waters.Environ Pollut202642264341PubTator, text miningPubMed
RPE Abnormality Is a Potential Primary Cause for Retinal Degeneration in Mucopolysaccharidosis Type VI Patients and a Rat Model.Invest Ophthalmol Vis Sci202642149031PubTator, text miningPubMed
Metagenomic insights into microbial community, antibiotic resistance genes, and virulence factor in Saryu River water, India.Environ Sci Pollut Res Int202642084683PubTator, text miningPubMed
Intracellular bioaccumulation outperforms surface display: A superior strategy for sustainable arsenic bioremediation through ArsR-ArsC coexpression.J Hazard Mater202642066611PubTator, text miningPubMed
Acute Airway Crisis in Mucopolysaccharidosis VI: Management Challenges.Diagnostics (Basel)202641975721PubTator, text miningPubMed
Microwave-Assisted Synthesis and Enzyme Stabilization Study of N‑Alkyl Praziquantel Analogs for Arylsulfatase B: Possible Leads for Mucopolysaccharidosis VI Therapy.ACS Omega202641970838PubTator, text miningPubMed
Polyglutamate-loaded chitosan nanogels reprogram plant metabolism for increased growth and viral resistance.Nat Commun202641896543PubTator, text miningPubMed

1 to 10 of 1,563

See all 1,563 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/411

GET https://conductscience.org/api/genes/v1/411/patents?page=2